Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marker Changes with Teriparatide in Severe Osteoporosis
NCT00532545Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Started Apr 2003; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00532545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532545.